CJC-1295 no DAC + Ipa 5mg/5mg

CJC-1295 (No DAC) + Ipamorelin Dual Peptide Blend – 10mg Vial (5mg / 5mg)

This dual-peptide combination brings together equal parts CJC-1295 (without DAC) and Ipamorelin, delivering 10 mg total peptide (5 mg of each) in a single freeze-dried glass vial for laboratory research.

Why Researchers Are Interested In It:

Because it targets two distinct receptor pathways involved in growth hormone signaling, this combination is a widely studied blend in lab research. Most of this work is done in cell cultures and tissue models, where scientists look at:

• Dual-pathway signaling: How activating two separate receptor types simultaneously influences signal transduction.
• Pulsatile release dynamics: How short-acting secretagogue combinations affect natural hormone release rhythms in cell models.
• Receptor selectivity: How targeted receptor activation triggers signaling without stimulating secondary endocrine pathways.

FOR LABORATORY RESEARCH USE ONLY: This product is a research chemical. It is not a drug, supplement, or medical product, and it is not intended for human or animal use, or for diagnosing, treating, or preventing any condition.

Receptors are like docking points on the surface of pituitary cells. In lab studies, CJC-1295 (No DAC) and Ipamorelin are evaluated for how they connect to two distinct receptor targets:

• GHRH Receptors (CJC-1295 No DAC): Binds to Growth Hormone Releasing Hormone receptors, triggering primary signal transduction inside pituitary cell models.
• Ghrelin / GHS Receptors (Ipamorelin): Selectively binds to ghrelin/growth hormone secretagogue receptors, providing a secondary signal amplification pathway.
• Dual Receptor Synergy: Studied in multi-agent cell assays to measure how co-activating both receptors works together compared to single-peptide ligands.

Please note that this research is preclinical (cell and lab work). This information is shared for educational purposes only.

• Product: CJC-1295 (No DAC) + Ipamorelin dual research peptide
• Vial Size: 10 mg total (5 mg CJC-1295 No DAC / 5 mg Ipamorelin)
• Structure: Modified GHRH derivative + Pentapeptide GH secretagogue
• Format: Freeze-dried (lyophilized) powder in a sealed glass vial
• Purity: ≥ 98.0% (verified by HPLC testing)
• Solubility: Water-soluble peptide complex
• Testing: See the Certificate of Analysis (COA) button above for this batch’s test results

Store sealed vials at -20°C (-4°F) or colder for long-term stability. Keep them dry and away from direct light. Avoid repeated temperature swings, which can break the peptide down over time.